Mount Sinai Cardiologists Recognized With Prestigious Honors at American College of Cardiology 68th Annual Scientific Session
Three of Mount Sinai’s top cardiologists will be recognized for their achievements at the 2019 American College of Cardiology Conference in New Orleans.
George Dangas, MD, PhD, Professor of Cardiology and Surgery at the Icahn School of Medicine at Mount Sinai and Director of The Zena and Michael A. Wiener Cardiovascular Institute at The Mount Sinai Hospital, will receive the 2019 Distinguished Fellowship Award for his outstanding contributions to the field of cardiovascular medicine. The College will present 19 of these awards at the Inauguration and Awards Ceremony on Monday, March 18.
Additionally, Robert Rosenson, MD, Professor of Cardiology and Director of Cardiometabolic Disorders at the Icahn School of Medicine at Mount Sinai, will be honored with the 2019 Simon Dack Award for outstanding scholarship. William Whang, MD, Associate Professor of Cardiology at the Icahn School of Medicine at Mount Sinai will also receive this distinction from the Journal of the American College of Cardiology (JACC). JACC recognizes the contributions and accomplishments of outstanding peer reviewers who assist the journal in its mission of publishing important new clinical information. Six recipients will receive this award during the JACC Editorial Board Meeting held in conjunction with the conference.
Dr. Dangas is an internationally recognized expert in coronary, heart valve, and vascular disease and specializes in minimally invasive interventional treatments with cutting-edge technologies in combination with novel medical therapy approaches. His active research interests include cardiovascular device therapy and its combination with anticlotting medications. He has authored more than 500 publications, including an international referral textbook on Interventional Cardiology Principles and Practice, and is the Associate Editor of the leading cardiology specialty journal, Journal of the American College of Cardiology (JACC). Additionally, he is a course director and invited/featured speaker in many of the top ranked cardiovascular conferences in the United States and around the world. Dr. Dangas has received Fellowship distinction in seven national and international professional societies and was a Trustee of the American College of Cardiology and of the Society for Cardiovascular Angiography and Interventions. He has received teaching awards since early in his career and is the American College of Cardiology Distinguished Teacher 2017.
Dr. Rosenson has received the Simon Dack Award for outstanding scholarship for four consecutive years. He is an internationally recognized researcher with ongoing research interests involving the effects of novel lipid-lowering therapy, inflammation, thrombogenesis, and rheology. His more recent interests extend to selective inhibitors of inflammatory pathways. He has authored more than 300 articles in peer-reviewed journals. In addition, he has written 700 book chapters and abstracts, as well as electronic publications for UpToDate Medicine (one of the most widely used medical resources in the world that gives point of care information for clinicians). Dr Rosenson is co-Editor in Chief for Cardiovascular Drugs and Therapy, Section Editor on Metabolic Disorders for JACC, and Section Editor on Lipid Disorders for UptoDate. Dr. Rosenson is a Fellow of the American Heart Association (AHA) Council on Arteriosclerosis, Thrombosis, and Vascular Biology, and the AHA Council on Epidemiology and Prevention. He is also a Fellow of the American College of Cardiology and American College of Physicians. Dr. Rosenson has long been an active member of the National Lipid Association and has served on its board of directors, program development committee, and expert panels. He has served as Principal Investigator (PI) on a number of studies funded by the National Institutes of Health, pharmaceutical-sponsored drug trials, and multicenter studies, and was Global PI of the PLASMA I, PLASMA II, and FRANCIS trials.
Dr. Whang is Director of Clinical Electrophysiology Research at The Mount Sinai Hospital and has active research interests in catheter ablation and new device technologies for patients with cardiac arrhythmia. He has published 88 manuscripts in journals including Circulation, JAMA, and JACC, as well as chapters in major cardiology textbooks including Hurst’s The Heart. He is a Fellow of the American Heart Association, the Heart Rhythm Society, and the New York Academy of Medicine. Previous research funding has included a career development award from the American Heart Association, the Lewis Katz research award for junior faculty at Columbia University, and an R01 grant from the National Heart, Lung, and Blood Institute. He is a practicing cardiac electrophysiologist who specializes in catheter ablation procedures and implantation of pacemakers/defibrillators and left atrial appendage closure devices.
“We congratulate Drs. Dangas, Rosenson, and Whang on these well-deserved honors for their commitment and dedication to enhancing the field of cardiovascular medicine,” said Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital. “These physicians exemplify the superb faculty and staff at Mount Sinai Heart who pride themselves on advancing cardiovascular research to ultimately provide world-class patient care.”
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and the South Nassau Communities Hospital is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.